Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 1
2010 1
2011 1
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD, Gercel-Taylor C. Taylor DD, et al. Gynecol Oncol. 2008 Jul;110(1):13-21. doi: 10.1016/j.ygyno.2008.04.033. Gynecol Oncol. 2008. PMID: 18589210
Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E, González-Barrios R, Cisneros-Soberanis F, Herrera-Goepfert R, Pérez V, Cantú D, Prada D, Castro C, Recillas-Targa F, Herrera LA. Soto-Reyes E, et al. BMC Cancer. 2012 Jan 25;12:40. doi: 10.1186/1471-2407-12-40. BMC Cancer. 2012. PMID: 22277129 Free PMC article.
MicroRNA signatures in human ovarian cancer.
Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM. Iorio MV, et al. Cancer Res. 2007 Sep 15;67(18):8699-707. doi: 10.1158/0008-5472.CAN-07-1936. Cancer Res. 2007. PMID: 17875710 Free article.
Discovery of novel microRNAs in female reproductive tract using next generation sequencing.
Creighton CJ, Benham AL, Zhu H, Khan MF, Reid JG, Nagaraja AK, Fountain MD, Dziadek O, Han D, Ma L, Kim J, Hawkins SM, Anderson ML, Matzuk MM, Gunaratne PH. Creighton CJ, et al. PLoS One. 2010 Mar 10;5(3):e9637. doi: 10.1371/journal.pone.0009637. PLoS One. 2010. PMID: 20224791 Free PMC article.
Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.
Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF. Chen J, et al. Gynecol Oncol. 2011 Apr;121(1):200-5. doi: 10.1016/j.ygyno.2010.12.339. Epub 2011 Jan 28. Gynecol Oncol. 2011. PMID: 21277012
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.
Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB. Lee CH, et al. PLoS One. 2009 Oct 2;4(10):e7314. doi: 10.1371/journal.pone.0007314. PLoS One. 2009. PMID: 19798417 Free PMC article.
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J. Laios A, et al. Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35. Mol Cancer. 2008. PMID: 18442408 Free PMC article.
MicroRNA expression and identification of putative miRNA targets in ovarian cancer.
Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W 3rd, Becker KG, Morin PJ. Dahiya N, et al. PLoS One. 2008 Jun 18;3(6):e2436. doi: 10.1371/journal.pone.0002436. PLoS One. 2008. PMID: 18560586 Free PMC article.
Feedback